Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)

F Barlesi, A Scherpenreel, A Rittmeyer, A Pazzola, N Ferrer Tur, Jung-Ha Kim, MJ Ahn, Joachim Aerts, V Gorbunova, A Vikstrom, EK Wong, P Perez-Moreno, L Mitchell, HJ Groen

Research output: Contribution to journalArticleAcademicpeer-review

274 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)3004-3011
Number of pages8
JournalJournal of Clinical Oncology
Issue number24
Publication statusPublished - 2013

Research programs

  • EMC MM-04-42-02

Cite this